Literature DB >> 3674115

A genetic follow-up study of 64 patients with the Pierre Robin complex.

L J Sheffield1, J A Reiss, K Strohm, M Gilding.   

Abstract

A genetic follow-up study has been performed of 64 infants who were diagnosed as having Pierre Robin complex over a 23-year period in South Australia. Patients and their families were contacted, family history was obtained, and physical examinations were performed with an aim to detect heterogeneity and establish recurrence risks. In 16 deceased patients, detailed autopsy reports allowed the conclusion that 12 (70%) had an underlying syndrome. Twelve of the 47 living patients (26%) were diagnosed as having an underlying syndrome, the most common of which was Stickler syndrome (6 cases). In most cases separation of syndromic cases from the nonsyndromic cases was possible in the neonatal period. In the 34 patients without an underlying syndrome, study of pregnancy and birth details did not reveal any distinctive etiologic factors. There was no recurrence in sibs of this group of patients with nonsyndromic Pierre Robin complex.

Entities:  

Mesh:

Year:  1987        PMID: 3674115     DOI: 10.1002/ajmg.1320280105

Source DB:  PubMed          Journal:  Am J Med Genet        ISSN: 0148-7299


  10 in total

1.  Neonatal mandibular distraction osteogenesis.

Authors:  Roberto L Flores
Journal:  Semin Plast Surg       Date:  2014-11       Impact factor: 2.314

2.  Clinical and Molecular Characterisation of Children with Pierre Robin Sequence and Additional Anomalies.

Authors:  Jessie X Xu; Nicky Kilpatrick; Naomi L Baker; Anthony Penington; Peter G Farlie; Tiong Yang Tan
Journal:  Mol Syndromol       Date:  2016-09-15

3.  Congenital double pylorus with accessory pyloric channel communicating with an intraluminal duplication cyst of the duodenum.

Authors:  M W Stannard; G Currarino; J B Splawski
Journal:  Pediatr Radiol       Date:  1993

4.  Congenital lesions associated with airway narrowing, respiratory distress, and unexpected infant and early childhood death.

Authors:  Marianne Rohde; Jytte Banner; Roger W Byard
Journal:  Forensic Sci Med Pathol       Date:  2005-06       Impact factor: 2.007

5.  Homozygous and compound-heterozygous mutations in TGDS cause Catel-Manzke syndrome.

Authors:  Nadja Ehmke; Almuth Caliebe; Rainer Koenig; Sarina G Kant; Zornitza Stark; Valérie Cormier-Daire; Dagmar Wieczorek; Gabriele Gillessen-Kaesbach; Kirstin Hoff; Amit Kawalia; Holger Thiele; Janine Altmüller; Björn Fischer-Zirnsak; Alexej Knaus; Na Zhu; Verena Heinrich; Celine Huber; Izabela Harabula; Malte Spielmann; Denise Horn; Uwe Kornak; Jochen Hecht; Peter M Krawitz; Peter Nürnberg; Reiner Siebert; Hermann Manzke; Stefan Mundlos
Journal:  Am J Hum Genet       Date:  2014-12-04       Impact factor: 11.025

6.  Pierre-Robin syndrome associated with Chiari type I malformation.

Authors:  Jangbo Lee; Kazutoshi Hida; Toshitaka Seki; Jun Kitamura; Yosinobu Iwasaki
Journal:  Childs Nerv Syst       Date:  2003-05-14       Impact factor: 1.475

7.  Mortality in Robin sequence: identification of risk factors.

Authors:  Robrecht J H Logjes; Maartje Haasnoot; Petra M A Lemmers; Mike F A Nicolaije; Marie-José H van den Boogaard; Aebele B Mink van der Molen; Corstiaan C Breugem
Journal:  Eur J Pediatr       Date:  2018-02-28       Impact factor: 3.183

8.  Genetics and management of the patient with orofacial cleft.

Authors:  Luciano Abreu Brito; Joanna Goes Castro Meira; Gerson Shigeru Kobayashi; Maria Rita Passos-Bueno
Journal:  Plast Surg Int       Date:  2012-11-01

9.  Disruption of SATB2 or its long-range cis-regulation by SOX9 causes a syndromic form of Pierre Robin sequence.

Authors:  Jacqueline K Rainger; Shipra Bhatia; Hemant Bengani; Philippe Gautier; Joe Rainger; Matt Pearson; Morad Ansari; Jayne Crow; Felicity Mehendale; Bozena Palinkasova; Michael J Dixon; Pamela J Thompson; Mar Matarin; Sanjay M Sisodiya; Dirk A Kleinjan; David R Fitzpatrick
Journal:  Hum Mol Genet       Date:  2013-12-20       Impact factor: 6.150

10.  Transferrin receptor facilitates TGF-β and BMP signaling activation to control craniofacial morphogenesis.

Authors:  R Lei; K Zhang; K Liu; X Shao; Z Ding; F Wang; Y Hong; M Zhu; H Li; H Li
Journal:  Cell Death Dis       Date:  2016-06-30       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.